MET
MetLife, Inc.
Stock
$94.16−1.04 (−1.09%)Close Sep 30, 2026
Income statement
| Line | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $79.4B | $77.1B | $71.0B | $66.9B | $68.8B |
| SG&A | $8.3B | $7.4B | $6.5B | $6.6B | $5.9B |
| Operating income | $6.6B | $6.1B | $6.0B | $5.7B | $6.0B |
| Non-operating income | −$1.7B | −$1.5B | −$374M | −$3.6B | $386M |
| Pretax income | $4.9B | $4.7B | $5.6B | $2.2B | $6.4B |
| Taxes | $1.2B | $1.3B | $1.2B | $584M | $1.1B |
| Net income | $3.6B | $3.4B | $4.4B | $1.6B | $5.3B |
| Diluted EPS | $5.23 | $4.71 | $5.94 | $1.81 | $6.30 |
| Diluted shares | — | 673.3M | 711.1M | 762.3M | 808.9M |
| Revenue growth | — | +8.6% | +6.1% | −2.7% | — |
| Operating margin | 8.3% | 8.0% | 8.4% | 8.6% | 8.7% |
| Net margin | 4.6% | 4.4% | 6.2% | 2.4% | 7.7% |
Cost of revenue, other operating expenses, non-operating income and taxes are the differences between the lines reported around them.